Skip to main content

Peer Review reports

From: Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report

Original Submission
2 Apr 2020 Submitted Original manuscript
29 Dec 2020 Reviewed Reviewer Report - Stergios Boussios
10 Jan 2021 Reviewed Reviewer Report - Malik Mohamed ATOUI
16 Feb 2021 Author responded Author comments - Rosa Montero-Macias
Resubmission - Version 2
16 Feb 2021 Submitted Manuscript version 2
1 Mar 2021 Editorially accepted
23 Apr 2021 Article published 10.1186/s13256-021-02767-9

You can find further information about peer review here.

Back to article page